versión imprimible
 
 

Ligase Targeting Drug Development Summit - May 2021 - Digital Event

Evvnt Promotion / evvnt
Archivo
-
25.05.2021 - 27.05.2021  Online
Time: 08:30 - 17:00
 
Temas de la conferencia
As the therapeutic value of manipulating previously hard-to-drug ubiquitin ligases becomes more and more evident in addressing numerous diseases with unmet clinical needs, the inaugural Ligase Targeting Drug Development Summit arrives as the dedicated scientific and networking forum for large pharma, innovative biotech and research institutes to seize the day.
Organizador profesional (PCO)
Hanson Wade
Observaciones
Speakers: Chris De Savi Vice President Head of Drug Discovery Kymera, Miklos Bekes Senior Research Investigator and Group Leader in Platform Biology Arvinas, Daniel Nomura Professor of Chemistry, University of California Berkeley and more.
 

Información e inscripción:

https://go.evvnt.com/717315-2?pid=4832
Mr. Customer Service
 
Categorías
Medicina General
Idioma
Inglés
Cuota del Congreso
Conference Only: USD 1999.0, Conference + 1 Workshop: USD 2348.0, Conference + 2 Workshops: USD 2697.0
Los participantes esperaban
1000
Cantacto organizador
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International fomenta el acceso a la educación y a la formación continua independientemente de fronteras sociales, geográficas y nacionales."

Anästhesie in Entwicklungsländern e. V.Österreichische Akademie der ÄrzteCenter of ExcellenceSwiss Tropical and Public Health InstitutenewTreeAlumni Club Medizinische Universität WienCharité International AcademyHilfswerk Austria